Tesamorelin for Lean Muscle and Fat Reduction — Performance & Recovery
FDA-approved GHRH analog for reducing visceral fat and supporting lean muscle mass.
Overview
Tesamorelin is an FDA-approved GHRH analog initially developed for HIV-associated lipodystrophy. It effectively reduces visceral adipose tissue while supporting lean muscle mass and metabolic function.
Indications
- Visceral fat reduction
- Body composition optimization
- Lean muscle mass support
Mechanism of Action
Excess visceral adipose tissue accumulates with aging or lipodystrophy, impairing metabolic function
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Tesamorelin | 2 mg | Once daily | Standard FDA-approved dosing |
Evidence Grade
GRADE A
Safety & Contraindications
- FDA-approved with established safety profile
- May affect glucose metabolism - monitor in diabetics
- Use sterile technique